Subscribe to RSS
DOI: 10.1055/s-2004-837246
Verbal Perseveration in Individuals with Alzheimer's Disease
Publication History
Publication Date:
15 December 2004 (online)
ABSTRACT
Perseveration has been described as a reliable indicator of disturbed brain function and is a common characteristic of neurological conditions such as Alzheimer's disease (AD). This article will begin with a review of recent theories that account for the phenomenon of perseveration, and data from a National Institute on Deafness and Other Communication Disorders (NIDCD)-supported study further delineate the nature of perseveration among individuals with AD. The study investigated the frequency of verbal perseveration in individuals with AD in relation to task type, mental status, and performance on attention and memory tests. Thirty Alzheimer's patients and 40 healthy elders were given a confrontation naming, generative naming, and picture description test. Perseveration was defined as a proportion of total number of responses. Data analysis revealed that individuals with AD perseverated more than normal elders did, but variability was high. Generative naming elicited more perseveration than either confrontation naming or picture description did. When overall frequency of perseveration was correlated with mental status and performance on attention and memory tests, seemingly paradoxical results were obtained, probably because the unique cognitive demands of each language test affected the probability of perseveration differently. Nonparadoxical, strong positive correlations were obtained, however, between language test scores and performance on tests of attention, memory and mental status.
KEYWORDS
Perseveration - Alzheimer's disease - mental status - memory
REFERENCES
- 1 Allison R S. Perseveration as a sign of diffuse and focal brain damaged. BMJ. 1966; 1027-1032
- 2 Jasper H H. Is perseveration a functional unit participating in all behavior processes?. J Soc Psychol. 1931; 2 28-50
- 3 Goldstein K. Language and Language Disturbances. New York; Grune and Stratton 1948: 916-918
- 4 Buckingham H W, Whitaker H, Whitaker H. On linguistic perseveration. In: Whitaker H, Whitaker H Studies in Neurolinguistics. New York; Academic Press 1979: 324-352
- 5 Santo Pietro M J, Rigrodsky S. Patterns of oral-verbal perseveration in adult aphasics. Brain Lang. 1986; 29 1-17
- 6 Cohen L, Dehaene S. Competition between past and present: assessment and interpretation of verbal perseverations. Brain. 1998; 121 1641-1659
- 7 Hasselmo M E, Bower J M. Cholinergic suppression specific to intrinsic not afferent fiber synapses in rat piriform (olfactory) cortex. J Neurophysiol. 1992; 67 1222-1229
- 8 Hasselmo M E. Runaway synaptic modification in models of cortex: implications for Alzheimer's disease. Neural Netw. 1994; 7 13-40
- 9 McNamara P, Albert M L. Neuropharmacology of verbal perseveration. Semin Speech Lang 2004 25: 309-322
- 10 Woolf N J. A possible role for cholinergic neurons of the basal forebrain and pontomesencephalon in consciousness. Conscious Cogn. 1997; 6 574-596
- 11 Perry E K, Walker M, Grace J, Perry R H. Acetylcholine in mind: a neural correlate of consciousness. Trends Neurosci. 1999; 22 273-280
- 12 Bartus R T, Dean R L, Beer B, Lippa A S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982; 217 408-417
- 13 Hasselmo M E, Bradley P, Wyble B P, Wallenstein G V. Encoding and retrieval of episodic memories: role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus. 1996; 6 693-708
- 14 Ghoneim M M, Mewaldt S P. Effects of diazepam and scopolamine on storage, retrieval and organization processes memory. Psychopharmacologia. 1975; 44 257-262
- 15 Peterson R C. Scopolamine induced learning failures in man. Psychopharmacology (Berl). 1977; 52 283-289
- 16 Ghoneim M M, Mewaldt S P. Studies on human memory; the interactions of diazepan, scopolamine and physostigmine. Psychopharmacology (Berl). 1977; 52 1-6
- 17 Bowen D M, Smith C B, White P, Davison A N. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 1976; 99 459-496
- 18 Bowen D M, White P, Spillane J A et al.. Accelerated ageing or selective neuronal loss as an important cause of dementia?. Lancet. 1979; i 11-14
- 19 Kasa P, Rakonczah Z, Gulya K. The cholinergic system in Alzheimer's disease. Prog Neurobiol. 1997; 1 511-535
- 20 Mesulam M M, Geula C. Overlap between acetylcholinesterase-rich and choline acetyltransferase-positive (cholinergic) axons in human cerbral cortex. Brain Res. 1992; 577 112-120
- 21 Mesulam M M, Mufson E J, Levey A I, Wainer B H. Alzheimer's disease and the cholinergic innervation of the neocortex by the nucleus basalis of Meynert. In: Katzman R Banbury Report 15: Biological Aspects of Alzheimer's Disease. New York; Cold Spring Harbor Laboratory 1982: 79-88
- 22 Perry E K, Tomlinson B E, Blessed G et al.. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ. 1978; 2 1457-1459
- 23 Bierer L M, Haroutunian V, Gabriel S et al.. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J Neurochem. 1995; 64 749-760
- 24 Cummings J L, Benson D F. Dementia: A Clinical Approach. Boston, MA: Butterworth. 1983
- 25 Albert M L, Sandson J. Perseveration in aphasia. Cortex. 1986; 22 103-115
- 26 Fuld P A, Katzman R, Davies P, Terry R D. Intrusions as a sign of Alzheimer dementia: chemical and pathological verification. Ann Neurol. 1982; 11 155-159
- 27 Wilson R S, Rosenbaum G, Brown G. The problem of premorbid intelligence in neuropsychological assessment. J Clin Neuropsychol. 1979; 1 49-53
- 28 McKhann G, Drachman D, Folstein M et al.. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34 939-944
- 29 Hachinski V C, Iliff L D, Zihka E et al.. Cerebral blood flow in dementia. Arch Neurol. 1975; 32 632-637
- 30 National Institute of Mental Health .The Diagnostic Interview Schedule. Washington, DC; NIMH Center for Epidemiological Studies 1979
- 31 Folstein M F, Folstein S E, McHugh P R. Mini-mental state: a practical method for grading cognitive state of patients for clinician. J Psychiatr Res. 1975; 12 189-198
- 32 Tombaugh T N, McIntyre N J. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992; 40 922-935
- 33 Farber J F, Schmitt F A, Logue P E. Predicting intellectual level from the Mini-Mental State Examination. J Am Geriatr Soc. 1988; 36 509-510
- 34 Wechsler D. Manual: Wechsler Adult Intelligence Scale-Revised. New York; Psychological Corporation 1981
- 35 Nelson H E. A modified Wisconsin card sorting test sensitive to frontal lobe defects. Cortex. 1976; 12 313-324
- 36 Wechsler D. Manual: Wechsler Memory Scale-Revised. New York; Psychological Corporation 1987
- 37 Bayles K A, Tomoeda C K. Arizona Battery for Communication Disorders of Dementia. Austin, TX; Pro-Ed 1993
- 38 Goodglass H, Kaplan E. Assessment of aphasia and related disorders, 2nd ed. Philadelphia; Lea & Febiger 1983
- 39 Helm-Estabrooks N, Emery P, Albert M L. Treatment of aphasic perseveration (TAP) program. Arch Neurol. 1987; 44 1253-1255
- 40 Tomoeda C K, Bayles K A. Longitudinal effects of Alzheimer disease on discourse production. Alzheimer Dis Assoc Disord. 1993; 7 223-236
- 41 Tomoeda C K, Bayles K A, Trosset M W, Azuma T, McGeagh A. Cross sectional analysis of Alzheimer's disease effects on oral discourse in a picture description task. Alzheimer Dis Assoc Disord. 1996; 10 204-215
- 42 Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ; Lawrence Erlbaum 1988
- 43 Bayles K A, Tomoeda C K, Kaszniak A W, Sterm L Z, Eagans K K. Verbal perseveration of dementia patients. Brain Lang. 1985; 25 102-116
- 44 Ramage A, Bayles K, Helm-Estabrooks N, Cruz R. Frequency of perseveration in normal subjects. Brain Lang. 1999; 66 329-340
- 45 Bayles K A, Salmon D P, Tomoeda C K et al.. Semantic and letter category naming in Alzheimer's patients: a predictable difference. Dev Neuropsychol. 1989; 5 335-347
- 46 Azuma T A, Bayles K A, Cruz R F et al.. Comparing the difficulty of letter, semantic, and name fluency tasks for normal elderly and patients with Parkinson's disease. Neuropsychology. 1997; 11 1-10
- 47 Rosen W G. Verbal fluency in aging and dementia. J Clin Neuropsychol. 1980; 2 135-146
- 48 Ober B A, Dronkers N F, Koss E, Delis D C, Friedland R P. Retrieval from sementic memory in Alzheimer-type dementia. J Clin Exp Neuropsychol. 1986; 8 75-92
- 49 Bayles K A, Tomoeda C K, Trosset M W. Relation of linguistic communication abilities of Alzheimer's patients to stage of disease. Brain Lang. 1992; 42 454-472
Kathryn A BaylesPh.D.
Department of Speech and Hearing Sciences, University of Arizona
P.O. Box 210071, Tucson
AZ 85721-0071
Email: bayles@email.arizona.edu